Intellia's Crispr Gene Editing Treatment Succeeds in Phase 3 Trial
Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, United States. Spencer Scholarship | Universal Image Group | fake images…
pharmaceutical products
The reality of Trump's drug prices will be set in the next 18 months
NovartisThe CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and that…
Regeneron signs drug pricing deal with Trump, will offer free hearing loss therapy
Regeneron He agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump,…
Regeneron weighs overseas pricing of gene therapy for rare hearing loss
Regeneron Pharmaceuticals will make its recently approved gene therapy for a rare genetic form of hearing loss available for free…
RFK Jr. says he would support a possible ban on junk food TV ads
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. gestures as he speaks during an event in the…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
The European pharmaceutical industry is in danger from Trump's policies and China's biotech boom
Boxes of medicines are seen on the shelves of Keencare pharmacy, a member of the Green Light Group, on September…
FDA approves leucovorin for brain folate deficiency, but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a…
Novo Nordisk ends legal proceedings against Hims & Hers
Nordisk has dropped its legal case against telehealth provider him and her for patent infringement, after the two companies agreed…
Eli Lilly (LLY) Earnings in Q4 2025
Eli Lilly on Wednesday released fourth-quarter earnings, revenue and 2026 guidance that beat estimates, as demand soars for its blockbuster…